123 related articles for article (PubMed ID: 32663707)
1. Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges.
Skrzypczak N; Pyta K; Ruszkowski P; Gdaniec M; Bartl F; Przybylski P
Eur J Med Chem; 2020 Sep; 202():112624. PubMed ID: 32663707
[TBL] [Abstract][Full Text] [Related]
2. Anticancer activity and toxicity of new quaternary ammonium geldanamycin derivative salts and their mixtures with potentiators.
Skrzypczak N; Pyta K; Ruszkowski P; Mikołajczak P; Kucińska M; Murias M; Gdaniec M; Bartl F; Przybylski P
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1898-1904. PubMed ID: 34344239
[TBL] [Abstract][Full Text] [Related]
3. Modifications of geldanamycin via CuAAC altering affinity to chaperone protein Hsp90 and cytotoxicity.
Skrzypczak N; Buczkowski A; Bohusz W; Nowak E; Tokarska K; Leśniewska A; Alzebari AM; Ruszkowski P; Gdaniec M; Bartl F; Przybylski P
Eur J Med Chem; 2023 Aug; 256():115450. PubMed ID: 37210951
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites.
Lee K; Ryu JS; Jin Y; Kim W; Kaur N; Chung SJ; Jeon YJ; Park JT; Bang JS; Lee HS; Kim TY; Lee JJ; Hong YS
Org Biomol Chem; 2008 Jan; 6(2):340-8. PubMed ID: 18175003
[TBL] [Abstract][Full Text] [Related]
5. Potent cytotoxic C-11 modified geldanamycin analogues.
Tian ZQ; Wang Z; MacMillan KS; Zhou Y; Carreras CW; Mueller T; Myles DC; Liu Y
J Med Chem; 2009 May; 52(10):3265-73. PubMed ID: 19405528
[TBL] [Abstract][Full Text] [Related]
6. An improved route to 19-substituted geldanamycins as novel Hsp90 inhibitors--potential therapeutics in cancer and neurodegeneration.
Kitson RR; Moody CJ
Chem Commun (Camb); 2013 Oct; 49(76):8441-3. PubMed ID: 23770604
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of geldanamycin analogs against human cancer cells.
Li YP; Chen JJ; Shen JJ; Cui J; Wu LZ; Wang Z; Li ZR
Cancer Chemother Pharmacol; 2015 Apr; 75(4):773-82. PubMed ID: 25681003
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of reblastatin, autolytimycin, and non-benzoquinone analogues: potent inhibitors of heat shock protein 90.
Wrona IE; Gozman A; Taldone T; Chiosis G; Panek JS
J Org Chem; 2010 May; 75(9):2820-35. PubMed ID: 20392070
[TBL] [Abstract][Full Text] [Related]
9. Rational design and synthesis of ansa-adenosines as potential antitumor agents.
Muranaka K; Ichikawa S; Matsuda A
Nucleic Acids Symp Ser (Oxf); 2009; (53):5-6. PubMed ID: 19749232
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamycin derivatives as potent Hsp90 inhibitors.
Li Z; Jia L; Wang J; Wu X; Hao H; Xu H; Wu Y; Shi G; Lu C; Shen Y
Eur J Med Chem; 2014 Oct; 85():359-70. PubMed ID: 25105924
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and structure--activity relationships for chimeric inhibitors of Hsp90.
Shen G; Wang M; Welch TR; Blagg BS
J Org Chem; 2006 Sep; 71(20):7618-31. PubMed ID: 16995666
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo Evaluation of 17-phenylpropylamine/phenoxyethylamine- 17-demethoxygeldanamycins as Potent Hsp90 Inhibitors.
Li Z; Jia L; Xu H; Lu C; Shena Y
Med Chem; 2015; 11(5):482-8. PubMed ID: 25537129
[TBL] [Abstract][Full Text] [Related]
13. New C-19-modified geldanamycin derivatives: synthesis, antitumor activities, and physical properties study.
Liu YF; Zhong JJ; Lin L; Liu JJ; Wang YG; He WQ; Yang ZY
J Asian Nat Prod Res; 2016 Aug; 18(8):752-64. PubMed ID: 26988280
[TBL] [Abstract][Full Text] [Related]
14. [Anticancer effect of 17-(6-cinnamamido-hexylamino-)-17-demethoxygeldanamycin: in vitro and in vivo].
Li L; Liu H; Zhang SH; Hu L; Zhen YS
Yao Xue Xue Bao; 2013 Dec; 48(12):1771-7. PubMed ID: 24689233
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel 17-phenylethylaminegeldanamycin derivatives as potent Hsp90 inhibitors.
Li Z; Jia L; Wang J; Wu X; Shi G; Lu C; Shen Y
Chem Biol Drug Des; 2015 Feb; 85(2):181-8. PubMed ID: 24903735
[TBL] [Abstract][Full Text] [Related]
16. Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
Li Z; Jia L; Wang J; Wu X; Hao H; Wu Y; Xu H; Wang Z; Shi G; Lu C; Shen Y
Eur J Med Chem; 2014 Nov; 87():346-63. PubMed ID: 25277067
[TBL] [Abstract][Full Text] [Related]
17. New geldanamycin derivatives with anti Hsp properties by mutasynthesis.
Hermane J; Eichner S; Mancuso L; Schröder B; Sasse F; Zeilinger C; Kirschning A
Org Biomol Chem; 2019 May; 17(21):5269-5278. PubMed ID: 31089638
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.
Zapf CW; Bloom JD; McBean JL; Dushin RG; Golas JM; Liu H; Lucas J; Boschelli F; Vogan E; Levin JI
Bioorg Med Chem Lett; 2011 Jun; 21(12):3627-31. PubMed ID: 21605975
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of macbecin as an Hsp90 inhibitor.
Martin CJ; Gaisser S; Challis IR; Carletti I; Wilkinson B; Gregory M; Prodromou C; Roe SM; Pearl LH; Boyd SM; Zhang MQ
J Med Chem; 2008 May; 51(9):2853-7. PubMed ID: 18357975
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of radamide analogues, a chimera of radicicol and geldanamycin.
Hadden MK; Blagg BS
J Org Chem; 2009 Jul; 74(13):4697-704. PubMed ID: 19492825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
